One of the four defendant Chinese companies has filed a proposed settlement in U.S. District Court in Brooklyn to resolve In re: Vitamin C Antitrust Litigation. The lawsuit, brought by commercial buyers of vitamin C, alleges that the companies formed a cartel to raise prices by limiting exports. The settlement calls for Aland Nutraceutical Co. (formerly Jiangsu Jiangshuan) to pay $9.5 million to direct purchasers, and $1 million to indirect purchasers.
Featured News
UK Government Orders Review of Daily Mail Owner’s £500 Million Telegraph Bid
Feb 12, 2026 by
CPI
FTC Warns Apple Over Alleged Political Bias in Apple News
Feb 12, 2026 by
CPI
California Is Cracking Down on Lawyers Who Let AI Do Their Homework
Feb 12, 2026 by
CPI
Google Under New EU Scrutiny Over Alleged Search Ad Price Manipulation
Feb 12, 2026 by
CPI
AI Agents Are Raising New Questions of Fraud and Privacy Liability
Feb 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Hub-&-Spoke Conspiracies
Jan 26, 2026 by
CPI
A Data Analytics Company as the Hub in a Hub-and-Spoke Cartel
Jan 26, 2026 by
Joseph Harrington
Hub and Spoke Cartels
Jan 26, 2026 by
Patrick Van Cayseele
Hub-and-Spoke Collusion or Vertical Exclusion? Identifying the Rim in Hub-and-Spoke Conspiracies
Jan 26, 2026 by
Rosa Abrantes-Metz, Pedro Gonzaga, Laura Ildefonso & Albert Metz
The Algorithmic Middleman in a Hub-and-Spoke Conspiracy: Divergent Court Decisions and the Expanding Patchwork of State and Local Regulations
Jan 26, 2026 by
Bradley C. Weber